These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16380680)

  • 1. Cyclin D1 expression in primary thyroid carcinomas.
    Sporny S; Slowinska-Klencka D; Ratynska M
    Neuro Endocrinol Lett; 2005 Dec; 26(6):815-8. PubMed ID: 16380680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
    Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
    Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma.
    Lee SH; Lee JK; Jin SM; Lee KC; Sohn JH; Chae SW; Kim DH
    Otolaryngol Head Neck Surg; 2010 Mar; 142(3):332-7. PubMed ID: 20172376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 protein expression in human thyroid gland and thyroid cancer.
    Temmim L; Ebraheem AK; Baker H; Sinowatz F
    Anat Histol Embryol; 2006 Apr; 35(2):125-9. PubMed ID: 16542178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer.
    Wang S; Lloyd RV; Hutzler MJ; Safran MS; Patwardhan NA; Khan A
    Mod Pathol; 2000 Aug; 13(8):882-7. PubMed ID: 10955455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.
    Saiz AD; Olvera M; Rezk S; Florentine BA; McCourty A; Brynes RK
    J Pathol; 2002 Oct; 198(2):157-62. PubMed ID: 12237874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Satacińska-Los E; Kulig A; Włoch J
    Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
    Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
    Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?
    Londero SC; Godballe C; Krogdahl A; Bastholt L; Specht L; Sørensen CH; Pedersen HB; Pedersen U; Christiansen P
    Acta Oncol; 2008; 47(3):451-7. PubMed ID: 17906980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene amplification and overexpression of oncoproteins in thyroid papillary cancer.
    Várkondi E; Gyory F; Nagy A; Kiss I; Ember I; Kozma L
    In Vivo; 2005; 19(2):465-70. PubMed ID: 15796211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression.
    Lantsov D; Meirmanov S; Nakashima M; Kondo H; Saenko V; Naruke Y; Namba H; Ito M; Abrosimov A; Lushnikov E; Sekine I; Yamashita Sh
    Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoblastoma expression in thyroid neoplasms.
    Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
    Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High nuclear grade, frequent mitotic activity, cyclin D1 and p53 overexpression are associated with stromal invasion in mammary intracystic papillary carcinoma.
    Zhang C; Zhang P; Hao J; Quddus MR; Steinhoff MM; Sung CJ
    Breast J; 2005; 11(1):2-8. PubMed ID: 15647071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of nuclear, cytoplasmic expression of galectin-3 with beta-catenin/Wnt-pathway activation in thyroid carcinoma.
    Weinberger PM; Adam BL; Gourin CG; Moretz WH; Bollag RJ; Wang BY; Liu Z; Lee JR; Terris DJ
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):503-10. PubMed ID: 17515507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis.
    Lee KH; Lee HE; Cho SJ; Cho YJ; Lee HS; Kim JH; Nam SY; Chang MS; Kim WH; Lee BL
    Pathobiology; 2008; 75(6):364-72. PubMed ID: 19096232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index.
    Basolo F; Caligo MA; Pinchera A; Fedeli F; Baldanzi A; Miccoli P; Iacconi P; Fontanini G; Pacini F
    Thyroid; 2000 Sep; 10(9):741-6. PubMed ID: 11041450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study.
    Lin BT; Brynes RK; Gelb AB; McCourty A; Amin MB; Medeiros LJ
    Mod Pathol; 1998 Nov; 11(11):1075-81. PubMed ID: 9831205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of p107 is correlated with anaplastic transformation in papillary carcinoma of the thyroid.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    Anticancer Res; 2003; 23(5A):3819-24. PubMed ID: 14666683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast.
    Lee A; Park WC; Yim HW; Lee MA; Park G; Lee KY
    Jpn J Clin Oncol; 2007 Sep; 37(9):708-14. PubMed ID: 17940078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.